STOCK TITAN
  1. Home
  2. News
  3. THRN

Thorne Healthtech Inc - THRN STOCK NEWS

Welcome to our dedicated news page for Thorne Healthtech (Ticker: THRN), a resource for investors and traders seeking the latest updates and insights on Thorne Healthtech.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Thorne Healthtech's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Thorne Healthtech's position in the market.

News
L Catterton Completes Acquisition of Thorne HealthTech, Inc.
Rhea-AI Summary
L Catterton successfully completes acquisition of Thorne HealthTech, Inc.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
acquisition
-
News
L Catterton and Thorne HealthTech, Inc. Announce Expiration of Tender Offer
Rhea-AI Summary
L Catterton and Thorne HealthTech, Inc. announced the expiration of the tender offer to purchase all shares of Thorne's common stock. 97.3% of the shares were tendered and not withdrawn, satisfying all conditions of the offer. The acquisition is expected to be completed on October 16, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.1%
Tags
none
-
News
Thorne HealthTech, Inc. Enters into Definitive Agreement to be Acquired by L Catterton for $10.20 Per Share in Cash
Rhea-AI Summary
L Catterton to acquire Thorne HealthTech for $10.20 per share in cash, representing a 94% premium to the unaffected price.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
29.19%
Tags
acquisition
News
Thorne HealthTech Reports Second Quarter 2023 Results
Rhea-AI Summary
Thorne HealthTech, Inc. (NASDAQ: THRN) reports a 33.1% increase in net sales to $72.7 million and a 35.7% growth in gross profit to $40.6 million for the second quarter of 2023. The company also raised its full-year guidance for net sales and gross margin, with updated ranges of $285 million to $290 million for net sales and 50% to 52% for gross profit as a % of net sales. Thorne HealthTech achieved a net income of $4.4 million and adjusted EBITDA of $12.5 million, leading to a diluted EPS of $0.08 and adjusted diluted EPS of $0.15. Additionally, the company earned CE Mark certification for its at-home blood sampling device in the European Union.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.82%
Tags
earnings
-
News
Thorne HealthTech Schedules Second Quarter 2023 Earnings Release and Conference Call for August 8
Rhea-AI Summary
Thorne HealthTech, Inc. (NASDAQ: THRN) will release its second quarter 2023 financial results on Aug. 8, 2023. The company will host a conference call to discuss the results on the same day at 5:00 p.m. (U.S. Eastern Time). Thorne HealthTech has withdrawn its participation in the Canaccord Genuity 43rd Annual Growth Conference on Aug. 10, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.59%
Tags
earnings
-
News
Thorne HealthTech to Participate in the Canaccord Genuity 43rd Annual Growth Conference on August 10
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.07%
Tags
conferences
News
THORNE LAUNCHES GLOBAL CAMPAIGN - BUILD TO LAST - WITH FATHER AND SON DUO DWYANE AND ZAIRE WADE
Rhea-AI Summary
Thorne HealthTech, Inc. (NASDAQ: THRN) announces its Build to Last campaign, featuring Dwyane Wade and his son Zaire, highlighting the company's commitment to innovative, high-quality, personalized health and wellness products. The campaign emphasizes the Wades' partnership with Thorne to share their wellness journey and promote Thorne's suite of premium nutritional supplements. Thorne's comprehensive approach to health and wellness is rooted in personalization and scientific rigor, empowering consumers to make choices to optimize their health at every age and life stage.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.19%
Tags
none
-
News
Thorne HealthTech's At-Home Blood Sampling Device - NanoDrop - Earns CE Mark Certification in the European Union
Rhea-AI Summary
Thorne HealthTech's NanoDrop device receives CE Mark certification, expanding the company's line of innovative health-care solutions. The device allows individuals to collect capillary whole-blood samples at home, making it suitable for decentralized clinical trials and at-home diagnostic testing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.97%
Tags
none
-
News
Thorne HealthTech to Participate in TD Cowen's 7th Annual Future of the Consumer Conference on June 7
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
conferences
News
Thorne HealthTech Enters into Research and Development Partnership with Arome Science to Develop Next-Generation Metabolomics Test
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.51%
Tags
partnership
Stock THRN logo
Thorne Healthtech Inc

Nasdaq:THRN

THRN Rankings

N/A Ranked by Market Cap
#116 Ranked by Stock Gains
N/A Ranked by Dividends

THRN Stock Data

550.63M
15.73M
73.8%
10.28%
0.52%
All Other Miscellaneous Chemical Product and Preparation Manufacturing
Manufacturing
Link
United States
New York

About THRN

preventive health care. personalized. thorne is a health and technology company that is disrupting prevention and wellness. by combining dietary and lifestyle recommendations with nutritional supplement intervention, thorne is at the forefront of personalized health, with a mission to help consumers take control of their health and live a healthy life. thorne provides at-home biomarker tests to bring the doctor to the consumer’s home. by leveraging its sophisticated analytical software, thorne helps consumers uncover health insights and confidently take action to optimize health outcomes. based on individual test results, thorne’s technology and team can deliver a personalized plan on what to eat, how to exercise, and which thorne supplements to take. thorne is the only supplement manufacturer to collaborate with mayo clinic is the proud partner of a number of 12 usa teams. for more information visit thorne.com.